Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.2 Million CAD | -57.28% |
| 2022 | 3.91 Million CAD | -30.65% |
| 2021 | 5.64 Million CAD | 141.88% |
| 2020 | 2.33 Million CAD | -69.05% |
| 2019 | 7.54 Million CAD | 141.83% |
| 2018 | 3.11 Million CAD | 6128.19% |
| 2017 | 50.07 Thousand CAD | 6.33% |
| 2016 | 47.09 Thousand CAD | -8.98% |
| 2015 | 51.74 Thousand CAD | -14.64% |
| 2014 | 60.61 Thousand CAD | 108.69% |
| 2013 | 29.04 Thousand CAD | -62.05% |
| 2012 | 76.53 Thousand CAD | 13.02% |
| 2011 | 67.72 Thousand CAD | -15.3% |
| 2010 | 79.95 Thousand CAD | 1074.96% |
| 2009 | 6805.00 CAD | 101.39% |
| 2008 | 3379.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 541.48 Thousand CAD | -4.81% |
| 2024 Q1 | 344.55 Thousand CAD | -61.64% |
| 2023 Q3 | 428.34 Thousand CAD | -46.48% |
| 2023 FY | 1.67 Million CAD | -57.28% |
| 2023 Q1 | 582.77 Thousand CAD | -51.0% |
| 2023 Q2 | 800.34 Thousand CAD | 37.33% |
| 2023 Q4 | 898.27 Thousand CAD | 109.71% |
| 2022 Q4 | 1.18 Million CAD | 56.67% |
| 2022 Q1 | 1 Million CAD | -63.56% |
| 2022 Q2 | 958.64 Thousand CAD | -5.0% |
| 2022 FY | 3.91 Million CAD | -30.65% |
| 2022 Q3 | 759.13 Thousand CAD | -20.81% |
| 2021 FY | 5.64 Million CAD | 141.88% |
| 2021 Q1 | 817.55 Thousand CAD | -2.96% |
| 2021 Q2 | 952.55 Thousand CAD | 16.51% |
| 2021 Q3 | 1.11 Million CAD | 17.09% |
| 2021 Q4 | 2.76 Million CAD | 148.25% |
| 2020 FY | 2.33 Million CAD | -69.05% |
| 2020 Q2 | 437.82 Thousand CAD | -1.52% |
| 2020 Q3 | 609.58 Thousand CAD | 39.23% |
| 2020 Q4 | 842.47 Thousand CAD | 38.2% |
| 2020 Q1 | 444.6 Thousand CAD | -49.53% |
| 2019 FY | 7.54 Million CAD | 141.83% |
| 2019 Q4 | 880.89 Thousand CAD | -51.97% |
| 2019 Q1 | 3.19 Million CAD | -67.01% |
| 2019 Q3 | 1.83 Million CAD | 12.0% |
| 2019 Q2 | 1.63 Million CAD | -48.66% |
| 2018 Q2 | 504.32 Thousand CAD | 68.94% |
| 2018 Q1 | 298.51 Thousand CAD | -75.61% |
| 2018 FY | 3.11 Million CAD | 6128.19% |
| 2018 Q3 | 1 Million CAD | 99.88% |
| 2018 Q4 | 9.67 Million CAD | 859.34% |
| 2017 Q2 | 26.76 Thousand CAD | 319.2% |
| 2017 Q1 | 6384.00 CAD | 61.87% |
| 2017 Q4 | 1.22 Million CAD | 6215.03% |
| 2017 Q3 | 19.37 Thousand CAD | -27.59% |
| 2017 FY | 50.07 Thousand CAD | 6.33% |
| 2016 Q2 | 16.47 Thousand CAD | 823.14% |
| 2016 FY | 47.09 Thousand CAD | -8.98% |
| 2016 Q3 | 12.98 Thousand CAD | -21.17% |
| 2016 Q4 | 3944.00 CAD | -69.64% |
| 2016 Q1 | 1785.00 CAD | -89.47% |
| 2015 Q2 | 14.57 Thousand CAD | 69.02% |
| 2015 Q4 | 16.94 Thousand CAD | 42.69% |
| 2015 FY | 51.74 Thousand CAD | -14.64% |
| 2015 Q3 | 11.87 Thousand CAD | -18.48% |
| 2015 Q1 | 8621.00 CAD | 9.28% |
| 2014 Q4 | 7889.00 CAD | -55.77% |
| 2014 Q1 | 9583.00 CAD | 70.79% |
| 2014 FY | 60.61 Thousand CAD | 108.69% |
| 2014 Q3 | 17.83 Thousand CAD | -58.99% |
| 2014 Q2 | 43.5 Thousand CAD | 353.93% |
| 2013 FY | 29.04 Thousand CAD | -62.05% |
| 2013 Q4 | 5611.00 CAD | 167.19% |
| 2013 Q3 | 2100.00 CAD | -81.56% |
| 2013 Q2 | 11.39 Thousand CAD | 551.23% |
| 2013 Q1 | 1749.00 CAD | -81.87% |
| 2012 Q1 | 32.98 Thousand CAD | 94.83% |
| 2012 Q4 | 9645.00 CAD | 34.74% |
| 2012 Q2 | 21.51 Thousand CAD | -34.76% |
| 2012 FY | 76.53 Thousand CAD | 13.02% |
| 2012 Q3 | 7158.00 CAD | -66.74% |
| 2011 Q2 | 36.89 Thousand CAD | 386.65% |
| 2011 Q3 | 5105.00 CAD | -86.16% |
| 2011 Q4 | 16.92 Thousand CAD | 231.62% |
| 2011 FY | 67.72 Thousand CAD | -15.3% |
| 2011 Q1 | 7582.00 CAD | -38.6% |
| 2010 Q2 | 14.15 Thousand CAD | 100.82% |
| 2010 Q1 | 7050.00 CAD | -86.91% |
| 2010 FY | 79.95 Thousand CAD | 1074.96% |
| 2010 Q4 | 12.34 Thousand CAD | 13.39% |
| 2010 Q3 | 10.89 Thousand CAD | -23.08% |
| 2009 Q3 | 4886.00 CAD | 142.0% |
| 2009 FY | 6805.00 CAD | 101.39% |
| 2009 Q1 | 1225.00 CAD | -40.1% |
| 2009 Q4 | 53.86 Thousand CAD | 1002.37% |
| 2009 Q2 | 2019.00 CAD | 64.82% |
| 2008 Q3 | 4516.00 CAD | 0.0% |
| 2008 Q4 | 2045.00 CAD | -54.72% |
| 2008 FY | 3379.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | 18.937% |
| Asep Medical Holdings Inc | 7.74 Million CAD | 45.644% |
| BetterLife Pharma Inc. | 3.24 Million CAD | -29.881% |
| BioVaxys Technology Corp. | 2.4 Million CAD | -75.162% |
| ChitogenX Inc. | 2.83 Million CAD | -48.709% |
| Defence Therapeutics Inc. | 12.65 Million CAD | 66.747% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | -645.763% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | 17.252% |
| Glow Lifetech Corp. | 25.71 Thousand CAD | -16265.759% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | -523.735% |
| Pharmala Biotech Holdings Inc. | 1.21 Million CAD | -245.792% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | -5738.022% |
| MYND Life Sciences Inc. | 1.47 Million CAD | -185.36% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | -250.034% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | -38.25% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | -336.959% |
| Telescope Innovations Corp. | 6.35 Million CAD | 33.749% |